missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Lymphotoxin alpha1/beta2 Protein
Click to view available options
Menge:
25 μg
Packungsgröße:
25 Mikrogramm
Beschreibung
The Recombinant Human Lymphotoxin alpha1/beta2 Protein is derived from HEK293. The Recombinant Human Lymphotoxin alpha1/beta2 Protein has been validated for the following applications: Bioactivity.
Spezifikation
Spezifikation
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Gen-ID (Entrez) | 4049 |
| Molekulargewicht | Observed M.W.: 65-76kDa, reducing conditions, Theoretical M.W.: 61kDa |
| Menge | 25 μg |
| Quelle | Human embryonic kidney cell,HEK293-derived human Lymphotoxin protein, (N-terminus) rhLT alpha (Leu35-Leu205) Accession &Num; P01374 GGGGS rhLT beta (Gln49-Gly244) Accession &Num; Q06643 GGGGS rhLT beta (Gln49-Gly244) Accession &Num; Q06643 (C-terminus) |
| Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Endotoxin-Konzentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Gebräuchliche Bezeichnung | Lymphotoxin |
| Gensymbol | LTA |
| Biologische Aktivität | Measured by its ability to induce IL-8 secretion by A375 human melanoma cells. The ED50 for this effect is typically 3-15ng/mL. |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur